Indemnity agreements under which the Company will indemnify and advance expenses to executive officers and directors.
| Officer | Age | 2024 pay | Source |
|---|---|---|---|
|
Steven Lo
Also a director
President, Chief Exec Officer
Title from the Form 4 dated Mar 24, 2026
|
58 | $2,085,768 | |
|
Jeroen Grasman
Chief Financial Officer
Title from the Form 4 dated May 19, 2026
|
Not stated | Not reported | |
|
James F. Cummings
Chief Medical Officer
Title from the Form 4 dated Mar 28, 2026
|
Not stated | $1,212,535 | |
|
Sean Tucker
SVP, Chief Scientific Officer
Title from the Form 4 dated Mar 28, 2026
|
Not stated | $1,155,031 | |
|
Edward B Berg
SVP, General Counsel
Title from the Form 4 dated Mar 24, 2026
|
Not stated | Not reported |
Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.
From the proxy statement filed Apr 10, 2025 · updated by the 8-Ks of Sep 2, 2025, Apr 23, 2026, and Oct 19, 2026
| Director | Age | On board | Independent | Committees | Other public boards | 2024 pay | Source |
|---|---|---|---|---|---|---|---|
|
Steven Lo
CEO
|
58 |
2024
1 year
|
Not independent | None stated | None stated | Paid as CEO | |
|
Kevin P. Finney
|
57 |
2025
this year
|
Independent |
Audit Committee
|
None stated | Not stated | |
|
Elaine J. Heron, Ph.D.
|
77 |
2022
3 years
|
Independent |
Compensation Committee
|
BioMarin Pharmaceutical Inc. | $143,779 | |
|
W. Mark Watson
|
74 |
2022
3 years
|
Independent |
Audit Committee · Chair
|
None stated | $142,881 | |
|
David Wheadon, M.D.
|
67 |
2021
4 years
|
Independent | None stated | None stated | $146,976 | |
|
James B. Breitmeyer
Joined Apr 23, 2026
|
- | - | Independent | - | - | - | |
|
Raquel C. Bono
Joined Oct 19, 2026
|
- | - | Independent | - | - | - |
Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive. A director marked Joined was added by an 8-K; their row opens that 8-K, and a dash is a value it does not give.
Indemnity agreements under which the Company will indemnify and advance expenses to executive officers and directors.
Separation Agreement entered into on January 31, 2024 with the former President and Chief Executive Officer.
Grants of stock options to executive officers and board members.
Loading...